https://www.indianpharmapost.com/pfizer-and-opko-update-on-the-biologics-license-application-for-somatrogon-111082022-01-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-expands-use-of-remdesivir-for-covid-19-111092022-01-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/lannett-receives-usfda-safety-review-for-biosimilar-insulin-glargine-111102022-01-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/positive-top-line-results-for-bimekizumab-in-second-phase-3-psoriatic-arthritis-study-111112022-01-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/molnupiravir-reduces-risk-of-hospitalisation-by-30-dr-shashank-joshi-111122022-01-22T00:00:00+05:30always0.9